Yes, that's a possibility. They could also deliver a deal that will help offset the need for a CR though.
There's no way to know, a point worth considering anyhow for those who are buying in. Speaking for myself (as I always do), not contemplating selling till the two Phase 2 trials data sets come out later in the year.
Always do your own research and take everything with a good dose of scepticism.
Ann: Updated Investor Presentation, page-13
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 31.5¢ | $1.478M | 4.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 107150 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 594669 | 9 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
